home / stock / adpt / adpt quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-01 | 56.95 | 57.89 | 59.09 | 56.95 | 656,358 |
2021-02-26 | 56.65 | 56.57 | 57.39 | 53.65 | 685,951 |
2021-02-25 | 55.04 | 55.31 | 57.99 | 53.955 | 1,622,844 |
2021-02-24 | 57 | 58.39 | 59.71 | 55.86 | 665,371 |
2021-02-23 | 56 | 56.76 | 57.44 | 52.66 | 912,410 |
2021-02-22 | 62.34 | 56.72 | 62.34 | 56.41 | 868,594 |
2021-02-19 | 61.39 | 63.21 | 64.33 | 60.84 | 641,912 |
2021-02-18 | 61.21 | 61.3 | 62.12 | 59.58 | 441,815 |
2021-02-17 | 62.92 | 62.12 | 63.985 | 60.94 | 595,576 |
2021-02-16 | 65.45 | 64.21 | 65.725 | 62.6 | 521,369 |
2021-02-15 | 64.96 | 66.5 | 67.34 | 63.93 | 579,157 |
2021-02-12 | 64.96 | 66.5 | 67.34 | 63.93 | 577,710 |
2021-02-11 | 63.24 | 64.37 | 64.59 | 62.51 | 508,587 |
2021-02-10 | 63.25 | 62.78 | 64.93 | 60.8005 | 415,072 |
2021-02-09 | 61.55 | 62.15 | 63.7094 | 61.34 | 347,892 |
2021-02-08 | 61.98 | 61.36 | 62.8369 | 60.81 | 595,746 |
2021-02-05 | 59.91 | 61.36 | 62.06 | 58.9 | 424,295 |
2021-02-04 | 59.59 | 59.31 | 60.07 | 58.01 | 386,056 |
2021-02-03 | 60.62 | 59.62 | 61.9145 | 58.79 | 497,178 |
2021-02-02 | 57.88 | 60.39 | 60.87 | 57.47 | 1,136,686 |
News, Short Squeeze, Breakout and More Instantly...
SEATTLE, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be particip...
Image source: The Motley Fool. Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Q4 2020 Earnings Call Feb 24, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Adaptive Biotechnologies Corporation (ADPT) Q4 2020 Ea...
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today...